- Home
- UNP vs ABT Comparison
UNP vs ABT Comparison
Compare UNP & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNP
- ABT
- Stock Information
- Founded
- UNP 1862
- ABT 1888
- Country
- UNP United States
- ABT United States
- Employees
- UNP N/A
- ABT N/A
- Industry
- UNP Railroads
- ABT Medical/Dental Instruments
- Sector
- UNP Industrials
- ABT Health Care
- Exchange
- UNP Nasdaq
- ABT Nasdaq
- Market Cap
- UNP 150.4B
- ABT 177.5B
- IPO Year
- UNP N/A
- ABT N/A
- Fundamental
- Price
- UNP $249.54
- ABT $113.95
- Analyst Decision
- UNP Buy
- ABT Strong Buy
- Analyst Count
- UNP 19
- ABT 9
- Target Price
- UNP $258.79
- ABT $124.33
- AVG Volume (30 Days)
- UNP 2.0M
- ABT 4.3M
- Earning Date
- UNP 10-17-2024
- ABT 10-16-2024
- Dividend Yield
- UNP 2.15%
- ABT 1.93%
- EPS Growth
- UNP N/A
- ABT 8.34
- EPS
- UNP 10.64
- ABT 3.17
- Revenue
- UNP $24,138,000,000.00
- ABT $40,725,000,000.00
- Revenue This Year
- UNP $2.05
- ABT $5.10
- Revenue Next Year
- UNP $5.10
- ABT $7.34
- P/E Ratio
- UNP $23.46
- ABT $35.92
- Revenue Growth
- UNP N/A
- ABT 1.24
- 52 Week Low
- UNP $199.33
- ABT $89.67
- 52 Week High
- UNP $258.66
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- UNP 55.88
- ABT 63.40
- Support Level
- UNP $242.83
- ABT $112.52
- Resistance Level
- UNP $258.07
- ABT $115.59
- Average True Range (ATR)
- UNP 3.69
- ABT 1.32
- MACD
- UNP 0.07
- ABT -0.03
- Stochastic Oscillator
- UNP 44.03
- ABT 68.82
About UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the us, UP generated $24 billion of revenue in 2023 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, fertilizers, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.